Histamine, a chemical compound notorious for triggering the uncomfortable symptoms of hay fever and allergic reactions, plays a starkly different and beneficial role in the human brain. According to a small-scale clinical experiment, elevating brain histamine levels can enhance memory recall accuracy by approximately 10 percent.
Researchers have long established that the brain contains specialized histamine receptors, densely distributed across regions associated with learning and memory. This connection explains why first-generation antihistamines, which crossed the blood-brain barrier, often induced cognitive side effects, leaving patients with temporary memory impairment. Until recently, however, scientists lacked a viable method to study the effects of elevated histamine levels on human cognition.
To overcome this hurdle, Michael Colwell and his colleagues at the University of Oxford utilized pitolisant, an existing medication approved for narcolepsy. Pitolisant functions by targeting histamine 3 receptors, thereby increasing the concentration of the neurotransmitter throughout the brain. In a study involving 60 healthy volunteers, half were administered pitolisant while the remaining half received a placebo. While undergoing MRI scans during various memory tasks, participants who received pitolisant exhibited heightened connectivity between the histamine-producing regions of the brain and the hippocampus, a critical hub for memory formation. Furthermore, these individuals demonstrated an 11 percent improvement in retrieving information they had learned during the scan.
Colwell suggests that this cognitive boost is linked to "novelty-linked arousal"—the level of alertness and engagement we experience when encountering new environmental stimuli. However, he cautions against using pitolisant off-label as a cognitive enhancer. Because the drug significantly alters sleep patterns, long-term abuse could ultimately degrade cognitive function rather than improve it.
Other experts view the findings as a promising step forward. Roland Seifert of Hannover Medical School noted that the study successfully translates previous animal findings to humans, which could stimulate further research into targeting histamine receptors to treat various neurological conditions. Additionally, Holger Stark from Heinrich Heine University in Düsseldorf, who contributed to the drug’s development, noted that while pitolisant has been shown to restore impaired cognitive function in patients with narcolepsy and Prader-Willi syndrome, its primary effect is normalizing compromised functions rather than elevating healthy cognition to superhuman levels. Ultimately, the dual function of histamine highlights evolutionary efficiency, demonstrating how the human body repurposes a single chemical for vastly different physiological processes.